Physician profile
Michael Grafe
NPI 1922194711
$6,195.88
in general payments reported to CMS, 2019-2025
11 companies · $406 in 2025
The $406 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.49 · 2020: $17.27 · 2021: $1,200 · 2022: $3,638 · 2023: $398 · 2024: $505 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,308.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $4,974.52 | 2021-2023 | |
| Stryker Corporation | $557.67 | 2023-2025 | Pangea, Variax, Evolve |
| Endo USA, INC. | $289.77 | 2024 | Xiaflex |
| Depuy Synthes Sales INC. | $106.98 | 2025 | Na |
| Bioventus LLC | $69.94 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $57.50 | 2023 | Iovera |
| Vertex Pharmaceuticals Incorporated | $46.47 | 2025 | |
| Derma Sciences, INC. | $31.49 | 2019 | |
| Hydrocision, INC. | $26.06 | 2025 | Tenjet |
| Fidia Pharma USA INC. | $18.21 | 2024 | Triluron |
| Zimmer Biomet Holdings, INC. | $17.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grafe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.